MergerLinks - Matthew D. Silverman

MajorityAcquisitionPrivatePrivate EquityCross Border

Software

target

ENVIANCE

bidder

Cority Software

value n/a

17 dealmakers

AcquisitionPublicMajorityTender Offer

target

Forty Seven

bidder

Gilead Sciences

£3,821m

48 dealmakers

MajorityPublicAcquisitionTender Offer

target

Portola Pharmaceuticals

bidder

Alexion Pharmaceuticals

£1,306m

50 dealmakers

DomesticMajorityPrivateAcquisition

FinTech

target

Hint

bidder

Revance Therapeutics

£147m

10 dealmakers

PrivateMajorityAcquisitionReverse TakeoverMergerDomesticPrivate EquityDe-SPAC

target

Nuvation Bio

bidder

Panacea Acquisition Corp

£650m

34 dealmakers

MajorityPublicAcquisitionCross Border

target

Viela Bio

bidder

Horizon Therapeutics

£2,262m

42 dealmakers

MajorityPrivateAcquisitionDomestic

target

Decipher Biosciences

bidder

VERACYTE

£439m

38 dealmakers

PrivateDomesticMajorityAcquisitionMergerPrivate Equity

Health Care Facilities

target

Iora Health

bidder

1life Healthcare

£1,483m

64 dealmakers

AcquisitionMajorityPrivatisationPrivate EquityDomesticPublic

Software

target

Cornerstone Ondemand

bidder

Clearlake Capital Group

£3,738m

103 dealmakers

United StatesUnited States

Medical Equipment

AcquisitionCross BorderPublicMajority

target

Intersect Ent

bidder

Medtronic

£790m

43 dealmakers

AcquisitionMergerDomesticPrivateMajorityReverse TakeoverPrivate EquityDe-SPAC

Computer Hardware

target

RIGETTI

bidder

Bessemer Venture Partners

£1,094m

58 dealmakers

PrivateMajorityDomesticAcquisition

target

Flexion Therapeutics

bidder

Pacira Biosciences

£462m

31 dealmakers

Telecommunications Equipment

AcquisitionDomesticMajorityMergerPublic

target

NEOPHOTONICS

bidder

Lumentum Holdings

£680m

83 dealmakers

DomesticMajorityPublicAcquisition

Health Care Services

target

Arena Pharmaceuticals

bidder

Pfizer

£5,052m

36 dealmakers

AcquisitionDomesticMergerPublicMajorityPrivatisation

Health Care Services

target

Turning Point Therapeutics

bidder

Bristol Myers Squibb Company

£3,270m

56 dealmakers

PrivateDomesticDe-SPACAcquisitionMajorityReverse Takeover

Medical Equipment

target

Suneva Medical

bidder

Viveon Health Acquisition

£168m

27 dealmakers

MajorityMergerPrivateAcquisitionDomestic

target

Silverback Therapeutics

bidder

Ars Pharmaceuticals

£120m

46 dealmakers

AcquisitionDomesticMajorityPublicPrivate Equity

E-commerce

target

Channeladvisor Corporation

bidder

Gtcr

£577m

49 dealmakers

AcquisitionPrivateDomesticMajority

Specialty Retailers

target

Aos Group

bidder

Starco Brands

value n/a

13 dealmakers

AcquisitionPublicMajorityDomesticMerger

target

Graybug Vision

bidder

CALCIMEDICA

value n/a

40 dealmakers

DomesticMajorityPublicAcquisition

Medical Supplies

target

Apollo Endosurgery

bidder

Boston Scientific Corporation

£508m

35 dealmakers

MajorityAcquisitionCross BorderPublicPrivate Equity

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

AcquisitionMajorityPrivateDomestic

target

Elicio Therapeutics

bidder

Angion Biomedica Corp

value n/a

30 dealmakers

MajorityAcquisitionDomesticPrivate

Distillers and Vintners

target

Winc (operating Assets)

bidder

Amass Brands

value n/a

9 dealmakers

DomesticPrivateMajorityAcquisitionMerger

target

Tourmaline Bio

bidder

Talaris Therapeutics

value n/a

32 dealmakers

AcquisitionMajorityPrivateDomesticReverse Takeover

target

Spyre Therapeutics

bidder

Aeglea Biotherapeutics

£86m

17 dealmakers

United StatesUnited States